Dr. Goodblatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Providence St. Peter Hospital
413 Lilly Rd NE
Olympia, WA 98516Phone+1 360-486-6402
Summary
- Dr. Michael Goodblatt is a family medicine and palliative care physician in Olympia, WA and is affiliated with Providence St. Peter Hospital. He received his medical degree from University of California San Diego School of Medicine. He completed residency training in Family Medicine at Harbor-UCLA in 2013 and spent 5 years in Anchorage, AK practicing broad-spectrum primary care including telemedicine and rural coverage in the interior of Alaska. He completed fellowship training in Hospice and Palliative Medicine at the University of Utah in Salt Lake City in 2019. He now works providing inpatient and outpatient palliative care.
Education & Training
- University of Utah HealthFellowship, Hospice and Palliative Medicine, 2017 - 2018
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Family Medicine, 2010 - 2013
- University of California San Diego School of MedicineClass of 2010
Certifications & Licensure
- WA State Medical License 2019 - 2026
- CA State Medical License 2011 - 2023
- AK State Medical License 2014 - 2021
- UT State Medical License 2018 - 2020
- American Board of Family Medicine Family Medicine
- American Board of Family Medicine Hospice and Palliative Medicine
Publications & Presentations
PubMed
- 21 citationsSynthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound.Harinath Chakrapani, Thomas C. Wilde, Michael L. Citro, Michael M. Goodblatt, Larry K. Keefer
Bioorganic & Medicinal Chemistry. 2008-03-01 - 13 citationsSynthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compoundHarinath Chakrapani, Michael M. Goodblatt, Vidya Udupi, Swati Malaviya, Paul J. Shami
Bioorganic & Medicinal Chemistry Letters. 2008-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: